Google Search

Search

Already a Member ?

Business Ideas: 3 - 3.5 Crore (Plant and Machinery): Selected Project Profiles for Entrepreneurs, Startups

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 5 of 5 | Total 46 projects in this category
« Previous   Page 1 2 3 4 5   »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Gypsum Plaster Board

Gypsum Plaster Boards are constructional sheets composed of consigned Gypsum with about 15% fibre. Its outstanding contributes are fire resistance, dimensional stability, easy workability and low cost fibres are added to provide crack resistance and for fire resistance water repellent chemicals may be added to the board core. Paper-coated gypsum board is made by method of adding small amount of additives and reinforced fiber to plaster as the base material and coating the surface and back of plasterboard with paper. Gypsum plaster boards are selected for use according to their type, size, thickeners and edge profit. The Boards may be used for example to provided dry lining finishes to masonry walls, to ceilings, to steel or timber framed partitions, or as claddings to structural steel columns and beams, or in the manufacture of pre-fabricated partition panels. The Indian market for Gypsum Plaster Board is expected to reach about 333.64 million m2 by 2021 from 221.75 million m2 in 2016, registering a Compounded Annual Growth Rate (CAGR) of 8.51% during the analysis period, 2016-2021BPB, UK took over the company and has acquired an 80% stock. The balance 20% of the capital is with the public. Gypsum Plaster Board (GPB) popularly known as gypboard is a low cost, lightweight construction material made from aerated gypsum plaster and produced in varying thicknesses suitable for different applications. It consists of a core of aerated gypsum plaster bonded between two sheets of heavy-duty paper. ? Few Indian major players are as under: • B P B India Gypsym Ltd. • Fact-R C F Building Products Ltd. • I D L Buildware Ltd. • I D L Salzbau (India) Ltd. • Saint-Gobain Gyproc India Ltd. • U S G Boral Building Products (India) Pvt. Ltd.
Plant capacity: Gypsum Plaster Board (Wall and Top Ceiling): 2,000,000 Sq.mt. per AnnumPlant & machinery: 315 Lakh
Working capital: -T.C.I: Cost of Project: 916 Lakh
Return: 27.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

Disposable Nitrile Gloves (Nitrile Examination Hand Gloves)

Disposable Nitrile Gloves (Nitrile Examination Hand Gloves) Nirile gloves are the perfect compromise between latex and vinyl. Nitrile is made from an allergy safe compound that feels a lot like latex but it’s much stronger, costs less, and is more comfortable to wear. Nitrile is perfect for demanding applications, especially cleaning and dishwashing. Nitrile gloves are commonly used as exam gloves, but due to their strength, lend themselves to multiple uses. Nitrile comes in powdered form, sterile, non-sterile and offered at different lengths from wrist to forearm. They are designed for multiple uses that include basic exam room checks, to hazardous materials handling, like working with chemotherapy chemicals. Powder Free Nitrile Gloves are anti-static in behavior, good solvent resistant, odour free, and hence useful in food and dairy industry. Powder-free gloves reduce the cause of allergies by lowering protein and chemical content. Powdered gloves are usually lubricated with cornstarch, which makes them much easier to put on. Cornstarch coatings have replaced other powdering options such as lycopodium powder and talc because these other coating types have been found to irritate tissue. Nevertheless, even cornstarch can impede healing when coming into contact with tissues, so powder-free gloves are often preferred for surgeries and other sensitive procedures. Special Features Latex-free, odour-free and powder-free Can Withstand IPA washing (ISO Propyl Alcohol). Can be used in food industry Ideal for doctors with latex allergy Nitrile gloves are primarily used in the medical sector as a safety tool to prevent the spreading of infection between caretakers and patients. The benefits offered by nitrile gloves include superior strength, longevity, and better protection against bloodborne pathogens. COVID-19 The outbreak of Novel coronavirus disease (now named COVID-19) was initially noticed from a seafood market in Wuhan city in Hubei Province of China in mid-December, 2019, has spread to more than 185 countries/territories worldwide including India. The causative agent for COVID-19, earlier termed provisionally as novel Coronavirus has been officially named as SARS-CoV-2. Mode of transmission There is clear evidence of human-to-human transmission of SARS-CoV-2. It is thought to be transmitted mainly through respiratory droplets that get generated when people cough, sneeze, or exhale. SARS-CoV-2 also gets transmitted by touching, by direct touch and through contaminated surfaces or objects and then touching their own mouth, nose, or possibly their eyes. Healthcare associated infection by SARS-CoV-2 virus has been documented among healthcare workers in many countries. The people most at risk of COVID-19 infection are those who are in close contact with a suspect/confirmed COVID-19 patient or who care for such patients. Nirile Gloves Role When a person touches an object/surface contaminated by COVID-19 infected person, and then touches his own eyes, nose, or mouth, he may get exposed to the virus. Although this is not thought to be a predominant mode of transmission, care should be exercised while handling objects/surface potentially contaminated by suspect/confirmed cases of COVID-19. Nitrile gloves are preferred over latex gloves because they resist chemicals, including certain disinfectants such as chlorine. There is a high rate of allergies to latex and contact allergic dermatitis among health workers. However, if nitrile gloves are not available, latex gloves can be used. Nonpowdered gloves are preferred to powdered gloves. The Global Nitrile Gloves Market is expected to reach USD 3.50 Billion by 2027. Growth in the incidences of epidemic diseases and the subsequent increase in the demand for infection prevention and control utilities are expected to drive the market demand in the forecast period. Asia Pacific market is estimated to witness the fastest growth rate of 6.5% in the nitrile gloves market. This can be chiefly attributed to the growth of the healthcare sector and the food processing industry in the leading countries in this region, especially China, India, and South Korea. Key players of the market are ompanies Ansell, Hartalega Holdings Berhad, Dynarex Corporation, United Glove Inc., Kossan Rubber Industries Ltd., Supermax Corporation Berhad, Rubberex, Adventa Berhad, Kimberly Clark and 3M among others.
Plant capacity: -Plant & machinery: 1
Working capital: 1T.C.I: 1
Return: 1.00%Break even: 1.00%
Add to Inquiry Add to Inquiry Basket

Disposable Surgical Face Mask & N95 Masks

A surgical mask is a loose-fitting, disposable mask that’s rectangular in shape. The mask has elastic bands or ties that can be looped behind ears or tied behind head to hold it in place. Which has better bacteria filtration and air permeability while remaining less slippery than woven cloth. The material most commonly used to make them is polypropylene, either 20 or 25 grams per square meter (gsm) in density. Masks can also be made of polystyrene, polycarbonate, polyethylene, or polyester. A properly worn three-ply surgical mask may help block transmission of large-particle microorganisms from droplets, sprays, splatters, and splashes. The mask may also reduce the likelihood of hand-to-face contact. N95 respirators are examples of personal protective equipment that are used to protect the wearer from airborne particles and from liquid contaminating the face. Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) and Occupational Safety and Health Administration (OSHA) also regulate N95 respirators. The 'N95' designation means that when subjected to careful testing, the respirator blocks at least 95 percent of very small (0.3 micron) test particles. If properly fitted, the filtration capabilities of N95 respirators exceed those of face masks. Using face-masks in public is very useful in minimising community transmission and burden of COVID-19, provided their coverage level is high. The masks coverage needed to eliminate COVID-19 decreases if the masks-based intervention is combined with strict social distancing strategy. Even the World Health Organization says wearing a medical mask is “one of the prevention measures to limit spread of certain respiratory diseases, including novel coronavirus (SARS-CoV-2), in affected areas”. Transmission through droplets from coughing and sneezing is one of the major routes of virus spread. When worn correctly, a mask can reduce the risk of inhaling droplets containing the virus. Surgical Mask Market size is forecast to reach $66.70 billion by 2025, growing at a CAGR of 5.76% during the forecast period 2020-2025. Advancements in the field of medical surgery and diagnosis and increase in the number of the medical device manufacturing companies along with the frequent outbreak of epidemics are the major factors driving the growth of the market. Increase in the adoption of surgical mask among general population and the rising advancements in the field of medical surgery is set to further enhance the overall market demand of surgical mask during the forecast period 2020-2025. Surgical mask market top companies are Thea Tex Healthcare Pvt. Ltd., Z Plus Disposable, Medicare Hygiene Limited, Mediblue Health Care Private Limited.,Nexera Medical, Planar Tech, Medline Industries Inc., Plasti Surge Industries Pvt. Ltd tc. The N95 mask market is expected to grow at a CAGR of 13.86% over the forecast period to reach US$2,034.594 million by 2025, increasing from US$933.793 million in 2019. Indian N95 mask market include 3M Company, Honeywell, Prestige Ameritech, Kimberly-Clark, Vega Corporation Co, Alpha Pro Tech, and Makrite among others/
Plant capacity: Surgical Face Mask:14400 Pcs Per Day: N95 Face Mask:14400 Pcs. Per DayPlant & machinery: 360 Lakhs
Working capital: N/AT.C.I: Cost of Project: 717 Lakhs
Return: 28.00%Break even: 40.00%
Add to Inquiry Add to Inquiry Basket

Surgical & N95 Masks

A surgical mask, also known as a procedure mask, medical mask or simply as a face mask, is intended to be worn by health professionals during surgery and during nursing to catch the bacteria shed in liquid droplets and aerosols from the wearer's mouth and nose. They are not designed to protect the wearer from inhaling airborne bacteria or virus particles and are less effective than respirators, such as N95 or FFP masks, which provide better protection due to their material, shape and tight seal. Surgical masks are designed to keep operating rooms sterile, preventing germs from the mouth and nose of a wearer from contaminating a patient during surgery. Although they have seen a rise in popularity among consumers during outbreaks such as the coronavirus, surgical masks are not designed to filter out viruses, which are smaller than germs. The India surgical mask market accounted for $58 million in 2017, and is projected to reach $95 million by 2025, registering a CAGR of 6.1% from 2018 to 2025. Surgical masks are made of natural fiber, such as cotton or disposable linen or synthetic materials, such as polypropylene. They are made of different layers including a hydrophobic outer layer, a middle filtering layer, and an inner hydrophilic layer to absorb the fluid and moisture. They are used as a barrier to avoid cross contamination by microorganisms and are used during surgical procedures. The surgical mask is used by surgeons during procedures and other medical professionals while interacting with the patients to avoid cross contamination of microorganisms. The India surgical mask market is driven by various factors, such as increase in elderly population, increase in adoption of surgical mask in the general population, and surge in prevalence of contagious and chronic diseases such as tuberculosis and asthma. Furthermore, rise in the number of medical device manufacturing companies is also anticipated to supplement the growth of the surgical masks industry. The demand within the global market for surgical mask has been rising on account of advancements in the field of medical surgery and diagnosis. Surgical masks are meant to protect doctors and surgeons from harmful infections and pathogens that may get suspended in the surgery room. Furthermore, the patient who is under treatment also needs to be protected from infectious agents that may be discharged by others in the surgery rooms. Hence, the global market for surgical mask is expected to expand at a stellar pace in the years to follow. There have been multiple attempts at manufacturing improved surgical masks, and this has given an impetus to market growth. The world is currently experiencing the pandemic of an infectious disease called COVID-19. This infection leads to multiple organ failure, acute & severe respiratory disorders, pneumonia, and even death in severe cases. Hence, surge in number of people with coronavirus infections is anticipated to drive the global surgical face masks market. According to the World Health Organization, globally, 823,626 confirmed and 72,736 new cases of COVID-19. The effectiveness of surgical face mask in blocking the transmission of SARS is 68%. Therefore, it is widely used by medical workers as part of droplet transmission precaution when caring for patients with respiratory infections. Hence, increase in use of surgical face masks is projected to fuel the growth of the global surgical face masks market. Furthermore, vulnerable populations, such as older adults with chronic conditions, are at high risk of infectious diseases, including COVID-19. Hence, the use of face mask to prevent infections by the geriatric population is anticipated to drive the global market. Few Indian major players are as under 3M India Ltd. Health Insurance T P A Ltd. GoodKimberly-Clark India Pvt. Ltd. Mediklin Healthcare Ltd. Surgeine Healthcare (India) Pvt. Ltd.
Plant capacity: Surgical Face Masks (each Pkts = 25 Pcs.): 1,694 Pkts / day N95 Face Masks (each Pkts = 5 Pcs.): 8,467 Pkts / dayPlant & machinery: Rs 350 lakhs
Working capital: -T.C.I: Cost of Project : Rs 865 lakhs
Return: 29.00%Break even: 53.00%
Add to Inquiry Add to Inquiry Basket

Active Pharma Ingredients (API) (Cephalexin, Ampicillin Trihydrate, Ibuprofen and Paracetamol)

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs. This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place. Cefalexin, is an antibiotic that can treat a number of bacterial infections. It kills gram-positive and some gram-negative bacteria by disrupting the growth of the bacterial cell wall. Cefalexin is a beta-lactam antibiotic within the class of first-generation cephalosporins. It works similarly to other agents within this class, including intravenous cefazolin, but can be taken by mouth. Cefalexin can be used in those who have mild or moderate allergies to penicillin. However, it is not recommended in those with severe penicillin allergies. Ampicillin is an antibiotic used to prevent and treat a number of bacterial infections, such as respiratory tract infections, urinary tract infections, meningitis, salmonellosis, and endocarditis. It may also be used to prevent group B streptococcal infection in newborns. It is used by mouth, by injection into a muscle, or intravenously. Like all antibiotics, it is not useful for the treatment of viral infections. Ampicillin is used to treat infections by many Gram-positive and Gram-negative bacteria. It was the first "broad spectrum" penicillin with activity against Gram-positive bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, some isolates of Staphylococcus aureus (but not penicillin-resistant or methicillin-resistant strains), Trueperella, and some Enterococcus. Paracetamol (acetaminophen) is a pain reliever and a fever reducer. The exact mechanism of action of is not known. Paracetamol is used to treat many conditions such as headache, muscle aches, arthritis, backache, toothaches, colds, and fevers. It relieves pain in mild arthritis but has no effect on the underlying inflammation and swelling of the joint. Paracetamol is generally safe at recommended doses. The recommended maximum daily dose for an adult is three to four grams. Higher doses may lead to toxicity, including liver failure. Serious skin rashes may rarely occur. It appears to be safe during pregnancy and when breastfeeding. In those with liver disease, it may still be used, but in lower doses. It is classified as a mild analgesic. It does not have significant anti-inflammatory activity. How it works is not entirely clear. Ibuprofen is a medication in the nonsteroidal anti-inflammatory drug (NSAID) class that is used for treating pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby. It can be used by mouth or intravenously. It typically begins working within an hour India's reliance on pharma ingredient imports has risen over the past few decades due to the higher cost of domestic production, with the price gap reaching as much as 20%-30%, particularly for energy-intensive fermentation-based ingredients used in anti-infectives. Import dependence is more than 90% for some life-saving drugs, including penicillin and ciprofloxacin. India is the seventh largest country in the world and has the second highest population. It has a parliamentary democratic form of government and has abundant natural resources and sufficient oil reserves. The country has a huge skilled, English-speaking, and inexpensive labor force. Its young population and current economic policies have made it one of the largest recipients of FDI in the world. Asia Pacific is expected to be the fastest-growing market over the forecast period. Owing to the availability of affordable labor, major companies in the market are setting up API manufacturing plants in developing countries such as China and India. The global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the market value is projected to reach US$ 258.8 Billion by 2025, exhibiting a CAGR of 5.6% during 2020-2025. The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. The emergence of COVID-19 has brought the world to a standstill. We perceive that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies will help within the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost each sector is anticipated to be impacted by the pandemic. The government also notified a scheme to promote bulk drug parks. For selected parks, financial assistance to the tune of 70 per cent of the project cost of common infrastructure facilities will be provided. In the case of Northeast states and hilly states (Himachal Pradesh, Uttarakhand, Union Territory of Jammu & Kashmir, and Union Territory of Ladakh), financial assistance will be 90 per cent of the project cost. The maximum assistance under the scheme for one bulk Drug Park will be limited to Rs 1,000 crore. The total financial outlay of the scheme is Rs 3,000 crore. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Few Indian major players are as under Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Cian Healthcare Ltd Cipla Ltd. Dr. Reddy'S Laboratories Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Indoco Remedies Ltd. Pan Drugs Ltd. Piramal Enterprises Ltd.
Plant capacity: Paracetamol: 500 Kgs / day Cephalexin: 500 Kgs / day Ampicillin Trihydrate: 500 Kgs / day Ibuprofen: 500 Kgs / dayPlant & machinery: Rs 347 lakhs
Working capital: -T.C.I: Cost of Project: Rs 1656 lakhs
Return: 36.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

Groundnut Oil

Groundnut oil is a vegetable oil derived from groundnuts. It is also called peanut oil. The oil has a strong peanut flavor and aroma. It is often used in American, Chinese, South Asian and Southeast Asian cuisine, both for general cooking, and in the case of roasted oil, for added flavor. Unrefined groundnut oil has a smoke point of 320°F/160°C and is used as a flavorant for dishes akin to sesame oil. Groundnut haulms are nutritious and widely used for feeding livestock. The groundnut oil is composed of mixed glycerides, and contain a high proportion of unsaturated fatty acids, in particular Oleic (50-56%) and Linoleic (18-30%). Cooking oil is an important and essential item in the FMCG sector. An average Indian consumes 15 Kg of oil in a year. Compared to other oils like sunflower oil, cottonseed oil, and soy oil, groundnut oil has more nutritional value. In addition to cooking, groundnut oil is used in the bakery and confectionery industry. Groundnut oil is used in soaps, salad oils, mayonnaise, etc. Groundnut oil is expensive compared to other oils. It has more vitamins, minerals, nutritional value and low levels of cholesterol. It is also suitable edible oil for Indian cooking. In India, groundnut is cultivated in 5.8 million hectares. Gujarat is the highest producer of groundnut oil in India. Groundnut seed contains 50-55% of the oil. It is one of the best oil seeds to extract oil from. Increasing use of groundnut oil in cosmetics are going to be one in all the primary drivers of the peanut oil market. The abrasive, volatizing, and cleansing properties of hot-pressed groundnut oil and its derivatives are boosting its application in BPC product and cosmetics, such as moisturizers and skin cleansers. Growing popularity of blended oil are going to be one in all the critical peanut oil market trends. The utilization of cheap alternatives, similar to vegetable oil in blended oil makes it more affordable than conventional oil. These advantages can boost the popularity of homogenized peanut oil and consequently fuel the growth of the peanut oil market. However, the high production cost of peanut oil is a major factor expected to restraint growth of the target market in the near future. In addition, high consumption of peanut oil results in various side effects in human health which is one of the major factors expected to hamper growth of the target market to a certain extent. Global peanut oil market is set to witness a steady CAGR of 4.25% in the forecast period of 2019- 2026. Groundnut oil is an all-purpose oil made from peanuts. It is generally used for it for its ‘nutty’ flavor and taste. It the oil is suitable for all types of cooking- frying, grilling and seasoning. Studies have shown that groundnut oil is just as effective in protecting against heart disease, as is olive oil. This is because it has similar properties and a similar fatty acid composition, as does olive oils. India is rated as the third largest producer of groundnut in the world with annual production of over 5-6 million tons. Gujarat, Andhra Pradesh, Tamil Nadu and Karnataka are the leading producers in the country and accounts for nearly 75% of the total output. Groundnut contributes to nearly 25% of total oil seed production in the country. As a whole any entrepreneur can venture in this project without risk and earn profit.
Plant capacity: Groundnut Oil (1 Ltr Pack each): 35,178 Packs / Day Groundnut Oil (5 Ltrs Pack each): 3,015 Packs / Day Groundut Cake (100 Kgs Bag each): 637.5 Bags / DayPlant & machinery: Rs 318 lakhs
Working capital: -T.C.I: Cost of Project: Rs 838 lakhs
Return: 30.00%Break even: 65.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 5 of 5 | Total 46 projects in this category
« Previous   Page 1 2 3 4 5   »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top